betulinic acid has been researched along with Inflammatory Bowel Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appendino, G; Calzado, MA; Collado, JA; García-Martín, A; Minassi, A; Muñoz, E; Palomares, B; Prados, ME; Unciti-Broceta, JD | 1 |
1 other study(ies) available for betulinic acid and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Betulinic Acid; Caco-2 Cells; Colon; Dextran Sulfate; Fibrosis; Gastrointestinal Agents; Gene Expression; Humans; Hydroxamic Acids; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NIH 3T3 Cells; Pentacyclic Triterpenes; Trinitrobenzenesulfonic Acid | 2021 |